IBDEI1MN ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29259,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29259,1,4,0)
 ;;=4^Chr Kidney Dis Stage IV
 ;;^UTILITY(U,$J,358.3,29259,1,5,0)
 ;;=5^585.4
 ;;^UTILITY(U,$J,358.3,29259,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,29260,0)
 ;;=202.80^^183^1856^3
 ;;^UTILITY(U,$J,358.3,29260,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29260,1,4,0)
 ;;=4^Lymphoma Nec Unspec Site
 ;;^UTILITY(U,$J,358.3,29260,1,5,0)
 ;;=5^202.80
 ;;^UTILITY(U,$J,358.3,29260,2)
 ;;=^87701
 ;;^UTILITY(U,$J,358.3,29261,0)
 ;;=782.2^^183^1856^33
 ;;^UTILITY(U,$J,358.3,29261,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29261,1,4,0)
 ;;=4^Local Suprficial Swellng
 ;;^UTILITY(U,$J,358.3,29261,1,5,0)
 ;;=5^782.2
 ;;^UTILITY(U,$J,358.3,29261,2)
 ;;=^71690
 ;;^UTILITY(U,$J,358.3,29262,0)
 ;;=401.9^^183^1856^13
 ;;^UTILITY(U,$J,358.3,29262,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29262,1,4,0)
 ;;=4^Hypertension NOS
 ;;^UTILITY(U,$J,358.3,29262,1,5,0)
 ;;=5^401.9
 ;;^UTILITY(U,$J,358.3,29262,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,29263,0)
 ;;=355.9^^183^1856^12
 ;;^UTILITY(U,$J,358.3,29263,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29263,1,4,0)
 ;;=4^Mononeuritis NOS
 ;;^UTILITY(U,$J,358.3,29263,1,5,0)
 ;;=5^355.9
 ;;^UTILITY(U,$J,358.3,29263,2)
 ;;=^78915
 ;;^UTILITY(U,$J,358.3,29264,0)
 ;;=171.9^^183^1856^2
 ;;^UTILITY(U,$J,358.3,29264,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29264,1,4,0)
 ;;=4^Mal Neo Soft Tissue NOS
 ;;^UTILITY(U,$J,358.3,29264,1,5,0)
 ;;=5^171.9
 ;;^UTILITY(U,$J,358.3,29264,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,29265,0)
 ;;=117.9^^183^1856^1
 ;;^UTILITY(U,$J,358.3,29265,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29265,1,4,0)
 ;;=4^Mycoses NOS
 ;;^UTILITY(U,$J,358.3,29265,1,5,0)
 ;;=5^117.9
 ;;^UTILITY(U,$J,358.3,29265,2)
 ;;=^87308
 ;;^UTILITY(U,$J,358.3,29266,0)
 ;;=415.19^^183^1856^14
 ;;^UTILITY(U,$J,358.3,29266,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29266,1,4,0)
 ;;=4^Pulm Emb & Infarc NEC
 ;;^UTILITY(U,$J,358.3,29266,1,5,0)
 ;;=5^415.19
 ;;^UTILITY(U,$J,358.3,29266,2)
 ;;=^303285
 ;;^UTILITY(U,$J,358.3,29267,0)
 ;;=780.60^^183^1856^29
 ;;^UTILITY(U,$J,358.3,29267,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29267,1,4,0)
 ;;=4^Fever NOS
 ;;^UTILITY(U,$J,358.3,29267,1,5,0)
 ;;=5^780.60
 ;;^UTILITY(U,$J,358.3,29267,2)
 ;;=^336764
 ;;^UTILITY(U,$J,358.3,29268,0)
 ;;=787.20^^183^1856^58
 ;;^UTILITY(U,$J,358.3,29268,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29268,1,4,0)
 ;;=4^Dysphagia NOS
 ;;^UTILITY(U,$J,358.3,29268,1,5,0)
 ;;=5^787.20
 ;;^UTILITY(U,$J,358.3,29268,2)
 ;;=^335307
 ;;^UTILITY(U,$J,358.3,29269,0)
 ;;=786.30^^183^1856^45
 ;;^UTILITY(U,$J,358.3,29269,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29269,1,4,0)
 ;;=4^Hemoptysis NOS
 ;;^UTILITY(U,$J,358.3,29269,1,5,0)
 ;;=5^786.30
 ;;^UTILITY(U,$J,358.3,29269,2)
 ;;=^339669
 ;;^UTILITY(U,$J,358.3,29270,0)
 ;;=787.60^^183^1856^62
 ;;^UTILITY(U,$J,358.3,29270,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29270,1,4,0)
 ;;=4^Incontinence of Feces
 ;;^UTILITY(U,$J,358.3,29270,1,5,0)
 ;;=5^787.60
 ;;^UTILITY(U,$J,358.3,29270,2)
 ;;=^339670
 ;;^UTILITY(U,$J,358.3,29271,0)
 ;;=294.20^^183^1856^10
 ;;^UTILITY(U,$J,358.3,29271,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29271,1,4,0)
 ;;=4^Dementia NOS
 ;;^UTILITY(U,$J,358.3,29271,1,5,0)
 ;;=5^294.20
 ;;^UTILITY(U,$J,358.3,29271,2)
 ;;=^340607
 ;;^UTILITY(U,$J,358.3,29272,0)
 ;;=435.2^^183^1856^15
 ;;^UTILITY(U,$J,358.3,29272,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29272,1,4,0)
 ;;=4^Subclavian Steal Syndrome
 ;;^UTILITY(U,$J,358.3,29272,1,5,0)
 ;;=5^435.2
 ;;^UTILITY(U,$J,358.3,29272,2)
 ;;=^115012
